![Avikal Malik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avikal Malik
Portfolio Manager-Aktien bei
J. Goldman & Co. LP
Profil
Avikal Malik currently works at J.
Goldman & Co. LP, as Healthcare Investor from 2025.
Mr. Malik also formerly worked at BofA Securities, Inc., as Research Analyst from 2019 to 2023 and Tri Locum Partners LP, as Research Analyst from 2023 to 2025.
Mr. Malik received his undergraduate degree from Panjab University Chandigarh, Masters Business Admin degree in 2017 from Stephen M.
Ross School of Business, and graduate degree from The City College of New York.
Aktive Positionen von Avikal Malik
| Unternehmen | Position | Beginn |
|---|---|---|
J. Goldman & Co. LP
 J. Goldman & Co. LP Investment ManagersFinance JGC seeks to achieve attractive risk-adjusted returns in all market conditions with low correlation and low volatility primarily through short-term trading in the equity and options markets. Their investment philosophy is based upon fundamental analysis, a comprehensive understanding of the capital markets and disciplined execution on investment ideas. The firm employs a rigorous process to identify, evaluate and allocate capital to the best ideas of its investment professionals. | Portfolio Manager-Aktien | 01.07.2025 |
Ehemalige bekannte Positionen von Avikal Malik
| Unternehmen | Position | Ende |
|---|---|---|
Tri Locum Partners LP
 Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Analyst-Equity | 01.07.2025 |
BofA Securities, Inc.
 BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.05.2023 |
Ausbildung von Avikal Malik
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
J. Goldman & Co. LP
J. Goldman & Co. LP Investment ManagersFinance JGC seeks to achieve attractive risk-adjusted returns in all market conditions with low correlation and low volatility primarily through short-term trading in the equity and options markets. Their investment philosophy is based upon fundamental analysis, a comprehensive understanding of the capital markets and disciplined execution on investment ideas. The firm employs a rigorous process to identify, evaluate and allocate capital to the best ideas of its investment professionals. | Finance |
Panjab University Chandigarh
 Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The City College of New York
 The City College of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BofA Securities, Inc.
BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Tri Locum Partners LP
Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Finance |
